Bilaketaren emaitzak - Alpesh Amin
- Erakusten 1 - 20 emaitzak -- 37
- Go to Next Page
-
1
Thromboprophylaxis rates in US medical centers: success or failure? nork Alpesh Amin, S Stemkowski, Jay Lin, Ge Yang
Argitaratua 2007Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials nork Steve Deitelzweig, Alpesh Amin, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham
Argitaratua 2012Artigo -
11
-
12
-
13
-
14
Attitudes and Preferences on the Use of Mobile Health Technology and Health Games for Self-Management: Interviews With Older Adults on Anticoagulation Therapy nork Jung‐Ah Lee, Annie L. Nguyen, Jill Berg, Alpesh Amin, Mark Bachman, YUQING GUO, Lorraine S. Evangelista
Argitaratua 2014Artigo -
15
-
16
Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start) nork Alpesh Amin, Alex C. Spyropoulos, Paul P. Dobesh, Andrew F. Shorr, Mohammed A. Hussein, Essy Mozaffari, Joshua S. Benner
Argitaratua 2009Artigo -
17
-
18
Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry) nork Mark E. Dunlap, Paul J. Hauptman, Alpesh Amin, Sandra L. Chase, Joseph Chiodo, Jun R. Chiong, Joseph F. Dasta
Argitaratua 2017Artigo -
19
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with w... nork Alpesh Amin, Allison Keshishian, Jeffrey Trocio, Oluwaseyi Dina, Hannah Le, Lisa Rosenblatt, Xianchen Liu, Jack Mardekian, Qisu Zhang, Onur Başer, Lien Vo
Argitaratua 2017Artigo -
20
Bilaketa egiteko lanabesak:
Antzeko gaiak
Medicine
Internal medicine
Intensive care medicine
Cardiology
Disease
Confidence interval
Environmental health
Heart failure
Population
Emergency medicine
Hazard ratio
Kidney disease
Cohort
Coronavirus disease 2019 (COVID-19)
Endocrinology
Hemodialysis
Infectious disease (medical specialty)
2019-20 coronavirus outbreak
Adverse effect
Biology
Chemistry
Dialysis
Outbreak
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Surgery
Virology
Atrial fibrillation
Blood pressure
Body mass index
Clinical trial